TNFRSF9 and myeloproliferative disorder: MPN patient derived cell lines (SET-2 and HEL) were incubated cultured in vitro (no stroma) alone, with HS-5 bone marrow cell line and with HS-5 conditioned media medium in the presence of Ruxolitinib and CD137 neutralizing antibody.